{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:25:14Z","timestamp":1707524714688},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,11,17]]},"DOI":"10.7759\/cureus.31600","type":"journal-article","created":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T13:46:10Z","timestamp":1668692770000},"source":"Crossref","is-referenced-by-count":0,"title":["Escitalopram Induced Angioedema"],"prefix":"10.7759","author":[{"given":"Samantha L","family":"Conde","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hani","family":"Nazha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cassandra","family":"Simpkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v57n1007b","article-title":"Paroxetine-induced angioedema and tongue swelling","volume":"57","author":"Mithani H","year":"1996","unstructured":"Mithani H, Hurwitz TA. Paroxetine-induced angioedema and tongue swelling. J Clin Psychiatry. 1996, 57:486. 10.4088\/JCP.v57n1007b","journal-title":"J Clin Psychiatry"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.9758\/cpn.2017.15.4.418","article-title":"Urticaria and angioedema associated with fluoxetine","volume":"15","author":"Tuman TC","year":"2017","unstructured":"Tuman TC, Tuman B, Polat M, \u00c7ak\u0131r U. Urticaria and angioedema associated with fluoxetine. Clin Psychopharmacol Neurosci. 2017, 15:418-9. 10.9758\/cpn.2017.15.4.418","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.5455\/annalsmedres.2019.01.052","article-title":"Probable \u201cescitalopram induced\u201d angioedema in a patient with hereditary angioedema","volume":"26","author":"Aytekin G","year":"2019","unstructured":"Aytekin G, Colkesen F, Y\u0131ld\u0131z E, Arslan S, Cal\u0131skaner A . Probable \u201cescitalopram induced\u201d angioedema in a patient with hereditary angioedema. Annals of Medical Research  . 2019, 26:951-4. 10.5455\/annalsmedres.2019.01.052","journal-title":"Annals of Medical Research"},{"key":"ref4","unstructured":"Wellbutrin (bupropion hydrochloride) Tablets - FDA Prescribing Information. (2009). Accessed. September 12, 2022: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2009\/018644s039s040.pdf."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.9422","article-title":"Effect of escitalopram vs placebo treatment for depression on long-term cardiac outcomes in patients with acute coronary syndrome: a randomized clinical trial","volume":"320","author":"Kim JM","year":"2018","unstructured":"Kim JM, Stewart R, Lee YS, et al.. Effect of escitalopram vs placebo treatment for depression on long-term cardiac outcomes in patients with acute coronary syndrome: a randomized clinical trial. JAMA. 2018, 320:350-8. 10.1001\/jama.2018.9422","journal-title":"JAMA"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-022-03303-4","article-title":"Selective serotonin reuptake inhibitors in the treatment of depression, anxiety, and post-traumatic stress disorder in substance use disorders: a Bayesian meta-analysis","volume":"78","author":"Fluyau D","year":"2022","unstructured":"Fluyau D, Mitra P, Jain A, Kailasam VK, Pierre CG. Selective serotonin reuptake inhibitors in the treatment of depression, anxiety, and post-traumatic stress disorder in substance use disorders: a Bayesian meta-analysis. Eur J Clin Pharmacol. 2022, 78:931-42. 10.1007\/s00228-022-03303-4","journal-title":"Eur J Clin Pharmacol"},{"key":"ref7","article-title":"Cardiovascular considerations in antidepressant therapy: an evidence-based review","volume":"8","author":"Yekehtaz H","year":"2013","unstructured":"Yekehtaz H, Farokhnia M, Akhondzadeh S. Cardiovascular considerations in antidepressant therapy: an evidence-based review. J Tehran Heart Cent. 2013, 8:169-76.","journal-title":"J Tehran Heart Cent"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2165\/11204760-000000000-00000","article-title":"Escitalopram: a review of its use in the management of major depressive disorder in adults","volume":"24","author":"Garnock-Jones KP","year":"2010","unstructured":"Garnock-Jones KP, McCormack PL. Escitalopram: a review of its use in the management of major depressive disorder in adults. CNS Drugs. 2010, 24:769-96. 10.2165\/11204760-000000000-00000","journal-title":"CNS Drugs"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo CA","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, et al.. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981, 30:239-45. 10.1038\/clpt.1981.154","journal-title":"Clin Pharmacol Ther"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/s0163-7258(99)00048-0","article-title":"Pharmacokinetics of selective serotonin reuptake inhibitors","volume":"85","author":"Hiemke C","year":"2000","unstructured":"Hiemke C, H\u00e4rtter S. Pharmacokinetics of selective serotonin reuptake inhibitors. Pharmacol Ther. 2000, 85:11-28. 10.1016\/s0163-7258(99)00048-0","journal-title":"Pharmacol Ther"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-00663-0_2","article-title":"Drug hypersensitivity reactions involving skin","author":"Hausmann O","year":"2010","unstructured":"Hausmann O, Schnyder B, Pichler WJ. Drug hypersensitivity reactions involving skin. Handb Exp Pharmacol. 2010, 29-55. 10.1007\/978-3-642-00663-0_2","journal-title":"Handb Exp Pharmacol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.4088\/pcc.v04n0601","article-title":"Escitalopram: a new SSRI for the treatment of depression in primary care","volume":"4","author":"Culpepper L","year":"2002","unstructured":"Culpepper L. Escitalopram: a new SSRI for the treatment of depression in primary care. Prim Care Companion J Clin Psychiatry. 2002, 4:209-14. 10.4088\/pcc.v04n0601","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.147","article-title":"Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 genotypes and dosing of selective serotonin reuptake inhibitors","volume":"98","author":"Hicks JK","year":"2015","unstructured":"Hicks JK, Bishop JR, Sangkuhl K, et al.. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 genotypes and dosing of selective serotonin reuptake inhibitors. Clin Pharmacol Ther. 2015, 98:127-34. 10.1002\/cpt.147","journal-title":"Clin Pharmacol Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/90910-escitalopram-induced-angioedema","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:49:00Z","timestamp":1707508140000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/90910-escitalopram-induced-angioedema"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,17]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.31600","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11,17]]}}}